Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
CVS Health is on track to expand its HealthHub store concept to more than 600 locations in 2020, the company revealed during a presentation at the J.P. Morgan Healthcare Conference in San Francisco.
Global healthcare company Cigna has partnered with New York-based health insurance startup Oscar Health to provide commercial health options to small businesses.
Patients and healthcare providers both see potential in AI’s ability to improve healthcare. Patients, however, appear to trust AI technology more than providers.
RSNA has announced that the official registration number for RSNA 2019 was 51,800, with another 6,754 participants registering for the online virtual meeting.
Heart failure (HF) is a significant problem, contributing to one in every eight deaths in the United States, but the risk prediction models currently available for HF remain limited at best.
Patients can now use AI to monitor their glucose levels with off-the-shelf, noninvasive wearable sensors, according to a new study published in Scientific Reports.
Radiomics and machine learning can help healthcare providers determine if late gadolinium enhancement (LGE) on cardiac MR images is a sign of myocardial infarction (MI) or myocarditis.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.